Clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients in all age groups over 7 to 8 years of continuous treatment with ozanimod (Zeposia).
Ozanimod (Zeposia) Controls MS Disease A... - My MSAA Community
Ozanimod (Zeposia) Controls MS Disease Activity Regardless of Age
Written by
BettysMom
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Nice that they studied older patients, too!
Something for older patients!
Not what you're looking for?
You may also like...
Investigational MS Med Nearly Eliminates Disease Activity on MRI
NASHVILLE, TENNESSEE — A second-generation anti-CD40L monoclonal antibody suppresses multiple...
Blood Test for MS Activity Gets FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the...
McDonald Criteria Revisions Signal Shift Toward MS as a Biologically Based Disease
An upcoming revised version of the McDonald diagnostic criteria for multiple sclerosis (MS) will...